1. Pentraxin 3 in primary percutaneous coronary intervention for ST elevation myocardial infarction is associated with early irreversible myocardial damage: Kinetic profile, relationship to interleukin 6 and infarct size. Issue 4 (1st June 2020) Authors: Butt, Noreen; Bache-Mathiesen, LK; Ushakova, A; Nordrehaug, JE; Jensen, SE; Munk, PS; Danchin, N; Dubois-Rande, JL; Hansen, HS; Paganelli, F; Corvoisier, P Le; Firat, H; Erlinge, D; Atar, D; Larsen, AI Journal: European heart journal Issue: Volume 9:Issue 4(2020) Page Start: 302 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Pentraxin 3 in primary percutaneous coronary intervention for ST elevation myocardial infarction is associated with early irreversible myocardial damage: Kinetic profile, relationship to interleukin 6 and infarct size. Issue 4 (June 2020) Authors: Butt, Noreen; Bache-Mathiesen, LK; Ushakova, A; Nordrehaug, JE; Jensen, SE; Munk, PS; Danchin, N; Dubois-Rande, JL; Hansen, HS; Paganelli, F; Corvoisier, P Le; Firat, H; Erlinge, D; Atar, D; Larsen, AI Journal: European heart journal Issue: Volume 9:Issue 4(2020) Page Start: 302 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗